RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KMPharmaceutical Co Stock

KMPharmaceutical Co Revenue 2024

KMPharmaceutical Co Revenue

17.77 B KRW

Ticker

225430.KQ

ISIN

KR7225430008

In 2024, KMPharmaceutical Co's sales reached 17.77 B KRW, a 13.68% difference from the 15.63 B KRW sales recorded in the previous year.

The KMPharmaceutical Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
202317.7727,63
202215.6320,63
202122.7124,94
202022.9325,91
201920.3428,45
201817.333,49
2017--
2016--
2015--

KMPharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into KMPharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by KMPharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects KMPharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of KMPharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into KMPharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing KMPharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on KMPharmaceutical Co’s growth potential.

KMPharmaceutical Co Revenue, EBIT and net profit per share

DateKMPharmaceutical Co RevenueKMPharmaceutical Co EBITKMPharmaceutical Co Net Income
202317.77 B KRW-1.09 B KRW-1.32 B KRW
202215.63 B KRW-1.25 B KRW-3.92 B KRW
202122.71 B KRW866.14 M KRW-611.19 M KRW
202022.93 B KRW712 M KRW471 M KRW
201920.34 B KRW-1.53 B KRW-902 M KRW
201817.3 B KRW1.57 B KRW-12.33 B KRW
20170 KRW-88 M KRW15 M KRW
20160 KRW-99 M KRW7 M KRW
20150 KRW-21 M KRW0 KRW

KMPharmaceutical Co stock margins

The KMPharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KMPharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KMPharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the KMPharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the KMPharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the KMPharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the KMPharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the KMPharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the KMPharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the KMPharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

KMPharmaceutical Co Margin History

KMPharmaceutical Co Gross marginKMPharmaceutical Co Profit marginKMPharmaceutical Co EBIT marginKMPharmaceutical Co Profit margin
202327.63 %-6.14 %-7.43 %
202220.63 %-7.97 %-25.11 %
202124.94 %3.81 %-2.69 %
202025.91 %3.11 %2.05 %
201928.45 %-7.5 %-4.44 %
201833.49 %9.09 %-71.26 %
201727.63 %0 %0 %
201627.63 %0 %0 %
201527.63 %0 %0 %

KMPharmaceutical Co Aktienanalyse

What does KMPharmaceutical Co do?

KMPharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding KMPharmaceutical Co's Sales Figures

The sales figures of KMPharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing KMPharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize KMPharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in KMPharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about KMPharmaceutical Co stock

How much revenue did KMPharmaceutical Co generate this year?

KMPharmaceutical Co has achieved a revenue of 17.77 B KRW this year.

How much was the turnover of the company KMPharmaceutical Co compared to the previous year?

The revenue of KMPharmaceutical Co has increased by 13.68% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of KMPharmaceutical Co?

The revenue of KMPharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of KMPharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of KMPharmaceutical Co so important for investors?

The revenue of KMPharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does KMPharmaceutical Co pay?

Over the past 12 months, KMPharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KMPharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of KMPharmaceutical Co?

The current dividend yield of KMPharmaceutical Co is .

When does KMPharmaceutical Co pay dividends?

KMPharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KMPharmaceutical Co?

KMPharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of KMPharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is KMPharmaceutical Co located?

KMPharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von KMPharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KMPharmaceutical Co from 12/24/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.

When did KMPharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/24/2024.

What was the dividend of KMPharmaceutical Co in the year 2023?

In the year 2023, KMPharmaceutical Co distributed 0 KRW as dividends.

In which currency does KMPharmaceutical Co pay out the dividend?

The dividends of KMPharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KMPharmaceutical Co

Our stock analysis for KMPharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KMPharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.